Patent Yard Sign in
Canadian application, no grantCanada

Methods for detecting genetic haplotypes by interaction with probes

CA 2463420 A1 · Owner: Singulex, Inc. · Inventors: Puskas, Robert S.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides methods for determining genetic haplotype comprising identifying target nucleic acids or gene fragments said nucleic , acids or gene fragments comprising a haplotype of interest and detecting at , least one parameter displayed by one of a primer-dependent transcript a , probe, or a primer-dependent transcript/probe complex. Further provided are methods for determining genetic haplotype comprising labeling nucleic acids or gene fragments with a least one probe, and detecting the velocity of the nucleic acid molecule or gene fragment by sequentially measuring at least one parameter displayed by the probes.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 24, 2002
GrantedNo grant recorded
Term endedOctober 24, 2022
Patent numberCA 2463420 A1
Classification (IPC)C12Q1/68

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedOct 24, 2002Term endedOct 24, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.